Pemetrexed tromethamine
| Code | Size | Price |
|---|
| TAR-T25929-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T25929-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T25929-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Pemetrexed tromethamine is a chemotherapy drug used for pleural mesothelioma and non-small cell lung cancer.
CAS:
1851348-04-3
Formula:
C28H47N7O14
Molecular Weight:
705.719
Purity:
0.98
SMILES:
O.O.NC(CO)(CO)CO.NC(CO)(CO)CO.Nc1nc2[nH]cc(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c2c(=O)[nH]1
References
1. Lin L, Zhao J, Hu J, Zou G, Huang F, Han J, He Y, Cao X. Current Smoking has a Detrimental Effect on Survival for Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) negative Advanced non-squamous Non-small Cell Lung Cancer (NSCLC) Patients Treated with Pemetrexed Continuation Maintenance. J Cancer. 2018 May 25;9(12):2140-2146. doi: 10.7150/jca.24872. eCollection 2018. PubMed PMID: 29937933; PubMed Central PMCID: PMC6010680.
2. Tang J, Li XY, Liang JB, Wu, Peng L, Li X. Copyright ? 2018 Cognizant Communication Corporation. Oncol Res. 2018 Jun 21. doi: 10.3727/096504018X15288447760357. [Epub ahead of print] PubMed PMID: 29929572.
3. Taniguchi Y, Horiuchi H, Morikawa T, Usui K. Small-Cell Carcinoma Transformation of Pulmonary Adenocarcinoma after Osimertinib Treatment: A Case Report. Case Rep Oncol. 2018 May 29;11(2):323-329. doi: 10.1159/000489603. eCollection 2018 May-Aug. PubMed PMID: 29928211; PubMed Central PMCID: PMC6006630.
4. Chapman D, Taj A. Pemetrexed-Induced Syncope. Am J Ther. 2018 Jun 15. doi: 10.1097/MJT.0000000000000803. [Epub ahead of print] PubMed PMID: 29927772.